secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0000950170-25-023958
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heron Therapeutics extends working capital loan maturity to Sept 2027 or earlier tied to convertible notes
--------------------------------------------------------------------------------

- Extended maturity to earlier of Sept 1, 2027, or (if 1.5% convertible notes remain) May 12, 2026.
- If note maturity extended beyond Aug 11, 2026, loan due 91 days prior to that extended date.
- Amendment with Hercules Capital, Inc. as agent and lender, dated Feb 13, 2025.
- Borrower reaffirms security grant and releases claims against lender as part of agreement.
- No changes to other terms; conditions precedent include representations and no default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000095017025023958/0000950170-25-023958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000095017025023958/hrtx-20250213.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-023958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer